AIT Therapeutics Reports Year End 2017 Financial Results

Mar 19, 2018 4:01pm EDT

AIT Therapeutics Announces Year End 2017 Financial Results Conference Call and Webcast

Mar 13, 2018 8:00am EDT

AIT Therapeutics to Present at Two Investor Conferences

Mar 07, 2018 4:05pm EST

AIT Therapeutics Appoints Two Senior Executives in Research and Clinical Operations

Feb 20, 2018 4:30pm EST

AIT Therapeutics Announces $9.82 Million Private Placement

Feb 16, 2018 11:03am EST

AIT Therapeutics Announces Completion of the Agreement to License the Revolutionary Nitric Oxide (NO) Generator and Delivery System

Jan 31, 2018 4:01pm EST

AIT Therapeutics Announces Further Data From Its NO-NTM Abscessus Phase 2 Clinical Trial in Nontuberculous Mycobacteria (NTM) Patients

Jan 22, 2018 8:00am EST

AIT Therapeutics Appoints Yoori Lee to its Board of Directors

Jan 02, 2018 9:45am EST

AIT Therapeutics Announces Publication of Its Phase 2 Trial in Bronchiolitis Patients in the Pediatric Pulmonology Journal

Dec 01, 2017 8:45am EST

AIT Therapeutics Announces Positive Preliminary Data for the Primary Endpoint of Safety in Its NO-NTM Abscessus Phase 2 Clinical Trial in Nontuberculous Mycobacteria (NTM) Patients

Nov 27, 2017 4:56pm EST